September 18, 2026
Georgiamune
Georgiamune, a Gaithersburg, Maryland-based clinical-stage biotech company, raised approximately $92.69 million in Series B funding for its cancer and autoimmune pipeline.
- Round
- Series B
- Amount raised
- $92.7M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- Gaithersburg
- Employees
- 11-50 employees
- Website
- georgiamune.com
- View profile →